MetLife, Inc. (MET) — Analyst outlook / Analyst consensus target is. Based on 32 analyst ratings, the consensus is bullish — 24 Buy, 8 Hold.
The consensus price target is $96.83 (low: $90.00, high: $101.00), representing an upside of 27.3% from the current price $76.04.
Analysts estimate Earnings Per Share (EPS) of $8.20 and revenue of $72.81B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $5.98 vs est $8.20 (missed -27.1%). 2025: actual $4.80 vs est $8.69 (missed -44.7%). Analyst accuracy: 41%.
MET Stock — 12-Month Price Forecast
$96.83
▲ +27.34% Upside
Average Price Target
Based on 32 Wall Street analysts offering 12-month price targets for MetLife, Inc., the average price target is $96.83, with a high forecast of $101.00, and a low forecast of $90.00.
The average price target represents a +27.34% change from the last price of $76.04.
Highest Price Target
$101.00
Average Price Target
$96.83
Lowest Price Target
$90.00
MET Analyst Ratings
Buy
Based on 32 analysts giving stock ratings to MetLife, Inc. in the past 3 months
EPS Estimates — MET
41%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual $5.98
vs Est $8.20
▼ 37.1% off
2025
Actual $4.80
vs Est $8.69
▼ 81.0% off
Profitability Outlook
Strong profitability with high earnings per share. EPS trend is declining. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — MET
94%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $69.897B
vs Est $72.805B
▼ 4.2% off
2025
Actual $77.084B
vs Est $83.068B
▼ 7.8% off
Revenue Trend
Moderate revenue growth trend. Analysts expect stable revenue going forward.
